These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1078 related articles for article (PubMed ID: 30593364)
41. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026 [TBL] [Abstract][Full Text] [Related]
42. A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus. Kim SH; Paldurai A; Samal SK Virology; 2017 Mar; 503():31-36. PubMed ID: 28110247 [TBL] [Abstract][Full Text] [Related]
43. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers. Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305 [TBL] [Abstract][Full Text] [Related]
44. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV. Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805 [TBL] [Abstract][Full Text] [Related]
45. Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken. Yang W; Dai J; Liu J; Guo M; Liu X; Hu S; Gu M; Hu J; Hu Z; Gao R; Liu K; Chen Y; Liu X; Wang X Viruses; 2022 Apr; 14(5):. PubMed ID: 35632659 [TBL] [Abstract][Full Text] [Related]
46. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. Nayak B; Rout SN; Kumar S; Khalil MS; Fouda MM; Ahmed LE; Earhart KC; Perez DR; Collins PL; Samal SK PLoS One; 2009 Aug; 4(8):e6509. PubMed ID: 19654873 [TBL] [Abstract][Full Text] [Related]
47. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947 [TBL] [Abstract][Full Text] [Related]
48. Non-thermal plasma for inactivated-vaccine preparation. Wang G; Zhu R; Yang L; Wang K; Zhang Q; Su X; Yang B; Zhang J; Fang J Vaccine; 2016 Feb; 34(8):1126-32. PubMed ID: 26529075 [TBL] [Abstract][Full Text] [Related]
49. Live recombinant Newcastle disease virus vectored vaccine expressing the haemagglutinin of H9N2 avian influenza virus suppresses viral replication in chickens. Lee J; Cho AY; Kim DH; Lee JB; Park SY; Choi IS; Lee SW; Song CS Avian Pathol; 2023 Apr; 52(2):100-107. PubMed ID: 36377478 [TBL] [Abstract][Full Text] [Related]
50. Recombinant-attenuated Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660 [TBL] [Abstract][Full Text] [Related]
51. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge. Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608 [TBL] [Abstract][Full Text] [Related]
52. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions. Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183 [TBL] [Abstract][Full Text] [Related]
53. Vaccine Efficacy Against a New Avian Influenza (H9N2) Field Isolate from the Middle East (Serology and Challenge Studies). Gharaibeh S; Amareen S Avian Dis; 2015 Dec; 59(4):508-11. PubMed ID: 26629624 [TBL] [Abstract][Full Text] [Related]
54. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens. Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723 [TBL] [Abstract][Full Text] [Related]
55. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine. Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117 [TBL] [Abstract][Full Text] [Related]
56. A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding. Xu X; Ding Z; Yuan Q; Ding J; Li J; Wang W; Cong Y; Ouyang W; Wang Y; Qian J; Yin R Vaccine; 2019 Jan; 37(3):444-451. PubMed ID: 30545716 [TBL] [Abstract][Full Text] [Related]
58. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine. Manoharan VK; Varghese BP; Paldurai A; Samal SK PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054 [TBL] [Abstract][Full Text] [Related]
59. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18. Chen HY; Shang YH; Yao HX; Cui BA; Zhang HY; Wang ZX; Wang YD; Chao AJ; Duan TY Antiviral Res; 2011 Jul; 91(1):50-6. PubMed ID: 21549153 [TBL] [Abstract][Full Text] [Related]
60. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens. Lee DH; Park JK; Kwon JH; Yuk SS; Erdene-Ochir TO; Jang YH; Seong BL; Lee JB; Park SY; Choi IS; Song CS PLoS One; 2013; 8(3):e58186. PubMed ID: 23469269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]